88. 慢性血栓塞栓性肺高血圧症 Chronic thromboembolic pulmonary hypertension Clinical trials / Disease details


臨床試験数 : 157 薬物数 : 107 - (DrugBank : 22) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 54

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2020-005462-34-DE
(EUCTR)
23/06/202125/02/2021Study to investigate the effect of riociguat on right heart size and function in pulmonary hypertensionAn open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension - RIVER II Symptomatic pulmonary arterial hypertension with a mean pulmonary artery pressure >20 mmHg and pulmonary vascular resistance =2 Wood Units, pulmonary arterial wedge pressure =15 mmHg (Group I / Nice Clinical Classification of Pulmonary Hypertension (PH)) or CTEPH (Group IV) with hemodynamics as stated above defined as inoperable measured at least 3 months after start of full anticoagulation or with persisting or recurrent PH after pulmonary endarterectomy at least 6 months after surgery
MedDRA version: 20.0;Level: HLT;Classification code 10037401;Term: Pulmonary hypertensions;System Organ Class: 100000004855;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Product Name: Riociguat
Product Code: MK-4836
INN or Proposed INN: RIOCIGUAT
Other descriptive name: BAY 63-2521
Product Name: Riociguat
Product Code: MK-4836
INN or Proposed INN: RIOCIGUAT
Other descriptive name: BAY 63-2521
Product Name: Riociguat
Product Code: MK-4836
INN or Proposed INN: RIOCIGUAT
Other descriptive name: BAY 63-2521
Product Name: Riociguat
Product Code: MK-4836
INN or Proposed INN: RIOCIGUAT
Other descriptive name: BAY 63-2521
Thoraxklinik Heidelberg gGmbHNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
30Phase 4Germany